Company intelligence / Profile preview

Pharmasynthese

Saint-Ouen-l'Aumône, Île-de-France, France

Ownership: Private
Employees: ~60
Development stage: Other

Overview

Pharmasynthese is a French Contract Development and Manufacturing Organization (CDMO) specializing in the custom synthesis of fine chemicals and active pharmaceutical ingredients (APIs). Founded in 1954 and currently a subsidiary of the Inabata Group, the company provides services ranging from laboratory-scale R&D to industrial-scale GMP production. Their expertise lies in complex multi-step organic synthesis, particularly for the pharmaceutical, cosmetic, and specialty chemical industries. The company operates a manufacturing site in Saint-Ouen-l'Aumône, France, equipped to handle diverse chemical reactions and purification processes.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Pharmasynthese.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pharmasynthese.

Explore the full profile